Geron Corp (GERN)

[rx7171]

From your transcript

>>Q Thanks. Finally, I may have missed this in the beginning from your prepared remarks but can you give us an update on, on the vaccine program and what's happening there.

DR. OKARMA: Yeah. Sure. And, and I – thank you. I didn't mention that. Imminently our IND will be submitted to the agency for a hematologic malignancy and at your conference, Ren, I'll unveil what that plan is,<<

When Tom refers to Ron's "conference" he is refering to the one on Nov 7-8.

So on that date we will be hearing more about the GRNVAC1 IND and its target.

No mention of a webcast, but hope for at least a PR.

Thanks for transcript Esammee

Bob